Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease
This article is part of the PlexusDx Education Hub your resource for evidence-based guidance on longevity protocols, peptide therapies, and the genetic variables that shape every metabolic and aging-related decision
Prescription GLP-1 and GIP/GLP-1 Peptides Semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda) are FDA-approved and have demonstrated significant weight reduction in large randomized controlled trials
Monitoring Response to Initial Therapy We watch for signs of improvement in symptoms and lab results
HYCOMIN is used for the prevention and treatment of Vitamin B12 deficiency, support for chronic fatigue related to B12 deficiency, maintenance of nervous system health, and enhancement of overall metabolic function
Stability & Storage Thanks to its synthetic structure and capsule formulation, 5-Amino-1MQ offers excellent stability under standard storage conditions